Gagnon Securities’s Pfizer PFE Stock Holding History

Gagnon Securities’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.24M	Sell	44,260 -93	-0.2%	-$2.48K	0.29%	43
2025 Q4	$1.1M	Buy	44,353 +1,193	+3%	+$30.1K	0.22%	49
2025 Q3	$1.1M	Sell	43,160 -63	-0.1%	-$1.55K	0.22%	48
2025 Q2	$1.05M	Buy	43,223 +3,432	+9%	+$80K	0.21%	46
2025 Q1	$1.01M	Buy	39,791 +4,315	+12%	+$113K	0.22%	52
2024 Q4	$941K	Sell	35,476 -1,766	-5%	-$47.9K	0.19%	50
2024 Q3	$1.08M	Sell	37,242 -366	-1%	-$10.7K	0.21%	49
2024 Q2	$1.05M	Sell	37,608 -768	-2%	-$21.1K	0.24%	49
2024 Q1	$1.06M	Buy	38,376 +2,454	+7%	+$68.1K	0.25%	49
2023 Q4	$1.03M	Buy	35,922 +4,918	+16%	+$149K	0.25%	47
2023 Q3	$1.03M	Sell	31,004 -3,144	-9%	-$111K	0.26%	49
2023 Q2	$1.25M	Buy	34,148 +3,612	+12%	+$141K	0.26%	48
2023 Q1	$1.25M	Buy	30,536 +4,617	+18%	+$199K	0.26%	46
2022 Q4	$1.33M	Sell	25,919 -4,120	-14%	-$198K	0.29%	45
2022 Q3	$1.31M	Sell	30,039 -3,393	-10%	-$165K	0.29%	46
2022 Q2	$1.75M	Sell	33,432 -950	-3%	-$48.4K	0.37%	44
2022 Q1	$1.78M	Buy	34,382 +425	+1%	+$22.1K	0.29%	46
2021 Q4	$2M	Hold	33,957	–	–	0.3%	43
2021 Q3	$1.46M	Hold	33,957	–	–	0.22%	52
2021 Q2	$1.33M	Sell	33,957 -225	-0.7%	-$8.75K	0.19%	57
2021 Q1	$1.24M	Buy	34,182 +15,913	+87%	+$565K	0.19%	57
2020 Q4	$672K	Buy	18,269 +1,215	+7%	+$44.6K	0.11%	62
2020 Q3	$594K	Sell	17,054 -13	-0.1%	-$456	0.13%	60
2020 Q2	$530K	Buy	17,067 +10,368	+155%	+$352K	0.13%	57
2020 Q1	$207K	Sell	6,699 -10,261	-61%	-$350K	0.07%	68
2019 Q4	$630K	Sell	16,960 -976	-5%	-$34.8K	0.14%	58
2019 Q3	$611K	Hold	17,936	–	–	0.14%	61
2019 Q2	$737K	Buy	17,936 +155	+0.9%	+$6.16K	0.16%	57
2019 Q1	$716K	Sell	17,781 -347	-2%	-$13.9K	0.16%	60
2018 Q4	$751K	Buy	18,128 +80	+0.4%	+$3.32K	0.2%	55
2018 Q3	$755K	Buy	18,048 +108	+0.6%	+$4.16K	0.17%	57
2018 Q2	$618K	Buy	17,940 +2,438	+16%	+$83.3K	0.18%	62
2018 Q1	$522K	Buy	15,502 +5,882	+61%	+$202K	0.19%	61
2017 Q4	$331K	Buy	9,620 +15	+0.2%	+$511	0.12%	70
2017 Q3	$325K	Hold	9,605	–	–	0.12%	67
2017 Q2	$306	Hold	9,605	–	–	0.08%	66
2017 Q1	$312K	Sell	9,605 -123	-1%	-$3.88K	0.14%	75
2016 Q4	$300K	Buy	9,728 +614	+7%	+$18.7K	0.13%	75
2016 Q3	$293K	Hold	9,114	–	–	0.12%	81
2016 Q2	$304K	Sell	9,114 -47	-0.5%	-$1.5K	0.14%	71
2016 Q1	$258K	Buy	+9,161	New	+$262K	0.12%	71

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Gagnon Securities's PFE Position: Q1 2026 in Review

Gagnon Securities reduced its Pfizer (PFE) stake by 0.21% in Q1 2026, selling an estimated $2.48K and leaving 44,260 shares worth $1.24M. The position accounts for 0.29% of the portfolio, ranked #43.

Gagnon Securities first reported a position in PFE in Q1 2016 and has held it in 41 quarters since. The position peaked at $2M in Q4 2021. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

Gagnon Securities held 44,260 shares of Pfizer worth $1.24M as of Q1 2026.
Gagnon Securities sold 93 Pfizer shares in Q1 2026, an estimated $2.48K.
Pfizer made up 0.29% of Gagnon Securities's portfolio in Q1 2026, its #43 holding.
Gagnon Securities first reported a position in Pfizer in Q1 2016 and has held it in 41 quarters since.
Gagnon Securities's Pfizer position peaked at $2M in Q4 2021.
2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Gagnon Securities's 13F filing for Q1 2026, filed 22 Apr 2026.